microdosing glp 1 for mcas GLP-1s in with Dr. Tania Dempsey - Mast Cell Matters: Deep dives on MCAS with Tania Dempsey, MD - Presented by The POTScast Microdosing" GLP-1: case studies and

Long-term efficacy and safety of combined insulin and glucagon-like peptide-1 therapy: evidence from the LEADER trial

Digital health companies such as Noom, Hims & Hers (HIMS), and even WeightWatchers (WW) all began offering compounded versions of popular weight-loss drugs this year essentially custom-made formulations for hundreds of dollars less than the brand-name options

If you are experiencing persistent GI symptoms while on one of these medications, a consultation with a gastroenterologist can help determine whether adjustments or further testing are needed

Hurtado MD, Tama E, Fansa S, Ghusn W, Anazco D, Acosta A, et al

The latter concentration makes measurement easier: 0.3ml equals 300mcg, 0.4ml equals 400mcg, and so on

Targeted profiling of arachidonic acid and eicosanoids in rat tissue by UFLC-MS/MS: Application to identify potential markers for rheumatoid arthritis